Skip to main content
. 2021 Apr 19;2021(4):CD013246. doi: 10.1002/14651858.CD013246.pub2

NCT00752531.

Methods Randomised intervention trial
Participants Moderate to severe COPD according to NHLBI/WHO GOLD classification (stages II to III)
Interventions (HAT)
Outcomes Clinical health, including lung function and respiratory symptoms, COPD‐related quality of life, exercise tolerance, urgent healthcare utilisation, self‐efficacy for COPD patients, activities of daily living
Notes Unable to find publication